REVENUE (Tables)

12 Months Ended

Dec. 31, 2024

Revenue from Contract with Customer [Abstract]

Schedule of revenue by segment by geographic area

Revenue by segment and geography based on shipped to locations for the years ended December 31, 2024, 2023 and 2022 were as follows:

	For the Year Ended December 31, 2024
Segment	Europe		Domestic		Latin America		Asia		Total
Aptar Pharma	$	806,606	$	556,642	$	47,124	$	232,780	$	1,643,152
Aptar Beauty	745,198		241,115		155,692		83,725		1,225,730
Aptar Closures	218,064		347,733		83,376		64,835		714,008
Total	$	1,769,868	$	1,145,490	$	286,192	$	381,340	$	3,582,890

	For the Year Ended December 31, 2023
Segment	Europe		Domestic		Latin America		Asia		Total
Aptar Pharma	$	779,929	$	495,057	$	52,074	$	193,933	$	1,520,993
Aptar Beauty	806,963		219,760		152,963		88,011		1,267,697
Aptar Closures	218,833		336,315		84,146		59,466		698,760
Total	$	1,805,725	$	1,051,132	$	289,183	$	341,410	$	3,487,450

	For the Year Ended December 31, 2022
Segment	Europe		Domestic		Latin America		Asia		Total
Aptar Pharma	$	683,217	$	446,821	$	38,483	$	192,735	$	1,361,256
Aptar Beauty	715,797		280,023		134,883		91,832		1,222,535
Aptar Closures	217,162		378,503		79,482		63,311		738,458
Total	$	1,616,176	$	1,105,347	$	252,848	$	347,878	$	3,322,249

Schedule of opening and closing balances of contract assets and contract liabilities

The opening and closing balances of our contract asset and contract liabilities are as follows:

	Balance as of December 31, 2023		Balance as of December 31, 2024		Increase/ (Decrease)
Contract asset (current)	$	18,033	$	12,571	$	(5,462)
Contract liability (current)	60,507		64,425		3,918
Contract liability (long-term)	37,756		40,551		2,795